Dashboard › Demo Universe › Summit Chemical
Summit Chemical · SMCH
DEMO DATAUNDERWRITING ASSUMPTIONPASSFinancial statements DEMO DATA ANALYST PROJECTION
| $M | FY2022A | FY2023A | FY2024A | FY2025A | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.5B | $2.7B | $2.6B | $2.6B | $2.4B | $2.3B | $2.3B | $2.4B | $2.4B |
| % growth | 10.2% | -1.9% | -1.9% | -7.8% | -3.9% | 1.5% | 2.0% | 2.0% | |
| Direct costs / COGS | $1.8B | $2.0B | $1.9B | $1.9B | $1.8B | $1.8B | $1.8B | $1.8B | $1.9B |
| Gross profit (NOI for real estate) | $686.0M | $742.5M | $702.3M | $676.0M | $551.4M | $502.2M | $523.8M | $548.6M | $574.1M |
| % margin | 28.0% | 27.5% | 26.5% | 26.0% | 23.0% | 21.8% | 22.4% | 23.0% | 23.6% |
| Operating expenses (cash, adjusted) | $269.5M | $297.0M | $291.5M | $286.0M | $263.7M | $253.4M | $257.2M | $262.4M | $267.6M |
| EBITDA (company-adjusted basis) | $416.5M | $445.5M | $410.8M | $390.0M | $287.7M | $248.8M | $266.6M | $286.2M | $306.5M |
| % margin | 17.0% | 16.5% | 15.5% | 15.0% | 12.0% | 10.8% | 11.4% | 12.0% | 12.6% |
| D&A | $122.5M | $135.0M | $132.5M | $130.0M | $119.9M | $115.2M | $116.9M | $119.3M | $121.6M |
| Share-based compensation | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| EBIT | $294.0M | $310.5M | $278.3M | $260.0M | $167.8M | $133.6M | $149.6M | $167.0M | $184.9M |
| Interest expense | $104.5M | $110.6M | $116.8M | $122.9M | $137.9M | $126.4M | $123.4M | $118.0M | $117.2M |
| EBT | $189.5M | $199.9M | $161.5M | $137.1M | $29.9M | $7.2M | $26.3M | $48.9M | $67.7M |
| Taxes | $47.4M | $50.0M | $40.4M | $34.3M | $7.5M | $1.8M | $6.6M | $12.2M | $16.9M |
| Net income (model basis) | $142.1M | $149.9M | $121.1M | $102.8M | $22.4M | $5.4M | $19.7M | $36.7M | $50.8M |
| Capex | $134.8M | $148.5M | $145.8M | $143.0M | $125.3M | $120.4M | $122.2M | $124.6M | $127.1M |
| Working capital & other cash items | $10.7M | $37.5M | ($7.5M) | ($7.5M) | ($25.6M) | ($9.4M) | $9.9M | $11.8M | $12.0M |
| Free cash flow | $119.2M | $98.9M | $115.4M | $97.3M | $42.6M | $9.6M | $4.6M | $19.5M | $33.3M |
Historical columns are fictional demo inputs. Projections flow from the selected scenario’s assumptions (Scenarios tab): interest accrues on beginning balances by tranche; floating tranches use MAX(SOFR, floor) + spread + scenario shock; PIK accrues to principal. FCF = net income + D&A + SBC + PIK − capex − ΔNWC / other. Impairments, restructuring and other one-offs are excluded from EBITDA and net income and sit in the cash plug.
Sources & data lineage (3)
| Source | Document | Data type | Period | Accession | Doc date | Retrieved | Class |
|---|---|---|---|---|---|---|---|
| CreditIQ demo dataset | Summit Chemical — illustrative financial statements FY2022–FY2025 | Income statement / cash flow | FY2022–FY2025 | — | 2026-03-31 | 2026-03-31 | DEMO DATA |
| CreditIQ demo dataset | Summit Chemical — illustrative capital structure & covenants | Debt schedule | As of 2026-03-31 | — | 2026-03-31 | 2026-03-31 | DEMO DATA |
| CreditIQ demo dataset | Illustrative indicative bid marks (% of par) | Market price | 2026-03-31 | — | 2026-03-31 | 2026-03-31 | DEMO DATA |